Cloxacillin

This classification denotes a penicillin antibiotic with the molecular formula C19H18ClN3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O6X5QGC2VB, chemically known as 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as cloxacillin, which bears US NIH Compound Identifier 6098. European Medicines Agency schedules Cloxacillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06780MIG. The term CLOXACILLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules cloxacillin in its Anatomical Therapeutic Chemical (ATC) Classification. CLOXACILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cloxacillin under HS 29411090 and SITC 54131. As of Q4 2014, CLOXACILLIN remains the US FDA Preferred Term for this commodity. Cloxacillin bears US NLM identifiers UMLS ID C0009077 and NCI Concept Code C61688. SMILES: CLC1C(C2NOC(C2C(=O)NC2C3SC(C(N3C2=O)C(=O)O)(C)C)C)CCCC1.